Streetbeat News

Stock Prices

ORKA

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This suggests that trading activities for a specific asset, potentially ORKA, were temporarily paused and are now set to resume.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:55 pm

PRAX

Praxis Precision Medicines shares rose after announcing positive topline results from its Phase 2 study of Relutrigine, which showed a 46% reduction in monthly motor seizures during the double-blind period.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:53 pm

LUCY

Innovative Eyewear (NASDAQ:LUCY) has announced agreements for the immediate exercise of warrants for 126,699 shares at a reduced price of $5/share, expecting to raise approximately $633,495. The funds will be used for working capital and general corporate purposes. New Series A and B warrants will also be issued.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:50 pm

VCIG

VCI Global shares rose following the announcement of securing an $18 million contract for IPO deals.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:46 pm

IDAI

Trust Stamp has announced a $2.0 million registered direct offering and warrant inducement. This financial move is likely to impact the company's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:45 pm

DKS

Dick's Sporting Goods shares rose as TD Cowen maintained a Buy rating and increased its price target from $266 to $270.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:43 pm

VLVLY

Volvo Trucks is set to launch a next-generation heavy-duty electric truck with a range of up to 600 km, marking a significant step in the electrification of heavy trucks. The new model, featuring advanced driveline technology, will be available in 2025.

Portfolio Pulse from Benzinga Neuro

September 03, 2024 | 12:42 pm

TCBP

TC Biopharm (TCBP) has dosed five new patients in its ACHIEVE Phase 2b trial, which is a significant step in their clinical development process.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:41 pm

SD

SandRidge Energy has significantly increased its capital expenditure forecast for FY24 from an initial range of $8M-$11M to a new range of $33M-$39M.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:41 pm

STOK

Stoke Therapeutics will present data on zorevunersen, a potential first disease-modifying treatment for Dravet syndrome, at the European Epilepsy Congress. The data from Phase 1/2a and OLE studies show significant seizure reduction and cognitive improvements.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm